Skip to content

INMED PHARMACEUTICALS INC.

INM

CIK 0001728328

← back to feed
Revenue (TTM)
$1.29M
−28.3% YoY Q3 May 2026
Net Income (TTM)
−$8.84M
−6.3% YoY Q3 May 2026
EPS Diluted (TTM)
−$3.62
+58.5% YoY Q3 May 2026
Gross Margin
95.0%
Q3 May 2026
Operating Margin
-787.3%
Q3 May 2026
Net Margin
-686.1%
Q3 May 2026
Free Cash Flow (TTM)
−$7.87M
Q3 May 2026
Cash
$5.16M
Q3 May 2026
Total Debt
$29.31K
Q3 May 2026
Shares Outstanding
3.31M sh
Q3 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings